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Abstract
 
The 3
 
 
 
-hydroxysteroid dehydrogenase (3
 
 
 
-HSD) isoenzymes play a key role in cellular steroid
hormone synthesis. Vaccinia virus (VV) also synthesizes steroid hormones with a 3
 
 
 
-HSD en-
zyme (v3
 
 
 
-HSD) encoded by gene A44L. Here we examined the effects of v3
 
 
 
-HSD in VV
disease using wild-type (vA44L), deletion (v
 
 
 
A44L), and revertant (vA44L-rev) viruses in a
murine intranasal model. Loss of A44L was associated with an attenuated phenotype. Early
(days 1–3) after infection with v
 
 
 
A44L or control viruses the only difference observed between
groups was the reduced corticosterone level in lungs and plasma of v
 
 
 
A44L-infected animals.
Other parameters examined (body weight, signs of illness, temperature, virus titres, the pulmo-
nary inflammatory infiltrate, and interferon [IFN]-
 
 
 
 levels) were indistinguishable between
groups. Subsequently, v
 
 
 
A44L-infected animals had reduced weight loss and signs of illness,
 
and displayed a vigorous pulmonary inflammatory response. This was characterized by rapid
 
recruitment of CD4
 
 
 
 and CD8
 
 
 
 lymphocytes, enhanced IFN-
 
 
 
 production and augmented
cytotoxic T lymphocyte activity. These data suggest that steroid production by v3
 
 
 
-HSD con-
tributes to virus virulence by inhibiting an effective inflammatory response to infection.
Key words: NK cell • CTL • glucocorticoid • virulence • immunomodulation
 
Introduction
 
The 3
 
 
 
-hydroxysteroid dehydrogenase/
 
 
 
5
 
-
 
 
 
4
 
isomerase (3
 
 
 
-
HSD)
 
*
 
 enzyme catalyses the conversion of 
 
 
 
5
 
-3
 
 
 
-hydrox-
ysteroids to 
 
 
 
4
 
-3-ketosteroids, a reaction that is required
for the biosynthesis of all classes of steroid hormones:
progesterone, mineralocorticoids, glucocorticoids (GCs), an-
drogens, and estrogens. The enzyme is expressed in classical
steroidogenic tissues (adrenal cortex, ovaries, and testis)
but also in the skin, liver, kidney, and lung (1–3). Multi-
ple isoforms of 3
 
 
 
-HSD exist in human, rat and mouse
tissues (4).
Steroids are important for the differentiation, growth,
and physiology of many mammalian tissues and have mul-
tiple effects within the immune system. GCs are potent
immunosuppressive and anti-inflammatory agents and are
used during organ transplantation, autoimmune disease,
and a broad spectrum of inflammatory diseases (5). Although
the precise mechanisms underlying their immunosuppressive
effects are unknown, GCs affect the immune system by
modulating cytokine production, antigen presentation and
the migration and cytotoxicity of immune cells (6–8).
 
Steroid hormones such as GCs affect bacterial, protozoan,
and viral infections (9). Sex hormones modulate immune re-
sponses and are implicated in sex-associated susceptibilities
to infectious agents, such as coxsackievirus (10, 11) and
hepatitis B virus (12, 13). Another example is the greater
severity of variola virus infections in pregnant women than
in men or nonpregnant women (14). This could be mim-
icked by the administration of steroids such as cortisone to
variola virus-infected macaque monkeys (15). Cortisone
administration also increased the severity of the primary in-
oculation lesion and delayed healing in guinea pigs (16) and
rabbits (17) infected with vaccinia virus (VV). Early leuko-
cyte infiltration was also reduced in rabbits inoculated with
VV (17).
Poxviruses express several proteins that inhibit compo-
nents of the host immune system including IFNs, comple-
ment, cytokines, and chemokines (18). VV strain Western
 
Reserve (WR) gene A44L encodes an intracellular 3
 
 
 
-HSD
that contributes to virulence after intranasal (19, 20) or in-
 
J.B. Moore’s present address is Millennium Pharmaceuticals, Inc., 640
Memorial Dr., Cambridge, MA 02139.
Address correspondence to Geoffrey L. Smith, Department of Virol-
ogy, Faculty of Medicine, Imperial College London, St. Mary’s Campus,
Norfolk Place, London W2 1PG, UK. Phone: 207-594-3972; Fax: 207-
594-3973; E-mail: glsmith@ic.ac.uk
 
*
 
Abbreviations used in this paper:
 
 BAL, bronchoalveolar lavage; GC, glu-
cocorticoid; 3
 
 
 
-HSD, 3
 
 
 
-hydroxysteroid dehydrogenase; VV, vaccinia
virus; WR, Western Reserve.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
1270
 
Steroid Hormone Synthesis Suppresses Inflammation
 
tradermal (21) infection of mice. This report examines the
role of the A44L protein in VV disease and viral clearance
using wild-type (vA44L), deletion (v
 
 
 
A44L), and rever-
tant (vA44L-rev) viruses in a murine intranasal model. We
show that early during infection loss of A44L is associated
with reduced levels of corticosterone, the natural murine
GC, in the plasma and lungs of v
 
 
 
A44L-infected mice,
but the body weights, signs of illness, inflammatory re-
sponse, and body temperature were unaltered. Subse-
quently, there was a more rapid recruitment of CD4
 
 
 
 and
CD8
 
 
 
 lymphocytes, enhanced IFN-
 
 
 
 production and
augmented CTL activity in the lungs of v
 
 
 
A44L-infected
mice. These data suggest that enhanced steroid production
by the A44L protein contributes to immunosuppression
during VV infection.
 
Materials and Methods
 
Cells and Viruses.
 
BS-C-1, CV-1, and TK
 
  
 
143 cells and VV
strains were grown as described previously (22). VV strain WR
was partially purified through sucrose cushions as described (23).
 
Construction of Recombinant Viruses.
 
A VV WR mutant lack-
ing 86% of the A44L gene (formerly vJM2, renamed v
 
 
 
A44L)
was described previously (19). A revertant virus (vA44L-rev) was
isolated by reinserting the A44L gene into its natural locus within
v
 
 
 
A44L. A 2318-bp HincII fragment containing the VV WR
A44L gene and flanking regions was cloned into the SmaI site of
pUC119, forming pJM5. This plasmid was transfected into
v
 
 
 
A44L-infected cells and mycophenolic acid-resistant viruses
were isolated as described (24). These were grown on hypoxan-
thine guanine phosphoribosyltransferase negative D980R cells in
the presence of 6-thioguanine and a plaque representing a rever-
tant virus (A44L-rev) was identified.
 
3
 
 
 
-HSD Assay.
 
CV-1 cells were mock-infected or infected
in triplicate with VV at 10 PFU/cell. At 10 h pi 3
 
 
 
-HSD activity
was measured by conversion of [
 
3
 
H]-pregnenolone to [
 
3
 
H]-
progesterone as previously described (19).
 
Assay for Virus Virulence.
 
Female, 6–8-wk-old BALB/c mice
were inoculated intranasally under general anesthesia with 10
 
4
 
 or
10
 
5
 
 PFU of VV in PBS on day 0. Each day, mice were weighed
and monitored for signs of illness, and those having lost 
 
 
 
25% of
their original body weight were killed. To determine virus titers
in organs, mice were killed and their lung, brains, livers, and
spleens were removed, dounce homogenized, frozen, and thawed
three times and sonicated. The titer of infectious virus was deter-
mined by plaque assay on BS-C-1 cells. All in vivo experiments
were repeated at least once and data shown are representative of
these multiple experiments.
 
Recovery of Bronchoalveolar Lavage and Lung Cells.
 
To obtain
bronchoalveolar lavage (BAL) fluid mice were killed and their
lungs were inflated five times with 1 ml of PBS containing 10 U/
ml of heparin through a blunted 23-gauge needle inserted into
the trachea. BAL was centrifuged (3,000 rpm, 10 min) and the
supernatant was frozen at –20
 
 
 
C until analysis of cytokines by
ELISA. BAL cells were treated with Tris-NH
 
4
 
Cl (0.14 M
NH
 
4
 
Cl in 17 mM Tris, adjusted to pH 7.2) to lyse erythrocytes,
washed twice, and resuspended in cold RPMI 1640 medium
containing 10% FBS. BAL cells were centrifuged onto glass
slides, dried, and stained with hematoxylin and eosin for differ-
ential cell counts. Single cell suspensions of lung cells were pre-
pared by sieving lungs through a 100-
 
 
 
m nylon mesh followed
 
by hypotonic lysis of erythrocytes. Cell viability was assessed us-
ing trypan blue exclusion.
 
Cytotoxic Assays.
 
NK cell cytotoxicity and VV-specific CTL
activity in lung cell suspensions was assayed in 
 
51
 
Cr-release assays.
NK-mediated lysis was tested on YAC-1 cells while P815 cells
(H-2
 
d
 
, mastocytoma) were used as targets for VV-specific CTL
lysis. Prior to labeling with Na
 
2
51
 
CrO
 
4
 
 (150 
 
 
 
Ci per 3 
 
 
 
 10
 
6
 
cells), P815 cells were mock-infected or infected with VV WR at
10 PFU/cell for 2 h at 37
 
 
 
C. Uninfected YAC-1 cells were la-
beled as above. Serial dilutions of effector cells were incubated in
triplicate cultures with either noninfected or VV-infected target
cells in 100 
 
 
 
l of RPMI 1640 containing 10% FBS in 96-well
V-bottomed plates at 37
 
 
 
C in 5% CO
 
2
 
. After 4 h (YAC-1) or 6 h
(P815) cells were pelleted and 50 
 
 
 
l of the supernatant was trans-
ferred to a Lumaplate-96 (Packard Instrument Co.) and counted
using a Packard Microplate Scintillation counter. The percentage
of specific 
 
51
 
Cr release was calculated as: specific lysis 
 
 
 
 [(experi-
mental release – spontaneous release)]/(total detergent release –
spontaneous release)] 
 
 
 
 100. The spontaneous release values
were always 
 
 
 
10% of total lysis.
In some experiments CD8
 
 
 
 cells were depleted from lung cell
suspensions by incubation at 37
 
 
 
C with an anti-CD8 mAb (clone
3.115 [25]) in the presence of human complement. Analysis by
flow cytometry demonstrated selective depletion of the CD8
 
 
 
cell population. Depleted cells were added to cytotoxicity assays
without adjustment for the reduced cell number.
 
ELISA for Cytokines.
 
IFN-
 
 
 
, IL-10, and IL-4 in BAL fluid
and culture supernatants was quantified using OptEIA kits from
BD Biosciences. Cytokine concentrations were calculated from a
standard curve and expressed as ng/ml.
 
Flow Cytometric Analysis of Cell Surface and Intracellular Anti-
gens.
 
Single cell suspensions of BAL cells were blocked with
10% normal rat serum and 0.5 
 
 
 
g of Fc block (BD Biosciences)
in FACS
 
®
 
 buffer (PBS containing 0.1% bovine serum albumin
and 0.1% sodium azide) on ice for 20 min. Cells were stained
with FITC anti-CD4, Tri-color anti-CD8 and PE-labeled anti-
CD3 or isotype antibody controls (all from Caltag). The distribu-
tion of cell surface markers was determined on a FACScan™
flow cytometer with CELLQuest™ software (Becton Dickin-
son). A lymphocyte gate was used to select at least 20,000 events.
To detect intracellular cytokines, 10
 
6
 
 lung cells/ml were stim-
ulated with 50 ng/ml PMA (Sigma-Aldrich), 500 ng/ml iono-
mycin (Calbiochem) in the presence of 10 
 
 
 
g/ml brefeldin A
(Sigma-Aldrich) for 5 h at 37
 
 
 
C. Cells were washed with FACS
 
®
 
buffer and stained with Tri-color anti-CD4 and FITC anti-CD8
for 30 min on ice and then fixed for 30 min at room temperature
with 2% paraformaldehyde in PBS. Samples were permeabilized
with 0.5% saponin in FACS
 
®
 
 buffer for 10 min. PE-conjugated
anti-mouse IFN-
 
 
 
 (clone XMG1.2; BD Biosciences) was added
for a further 30 min at room temperature and the cells were
washed once with 0.5% saponin in FACS
 
®
 
 buffer and twice in
FACS
 
®
 
 buffer alone. Cells were analyzed on a Becton Dickinson
flow cytometer collecting data on at least 20,000 lymphocytes.
 
Corticosterone Levels in Plasma and Lung.
 
To guard against
fluctuations due to circadian rhythm, samples were obtained be-
tween 9:00 and 10:00 a.m. Mice were killed by cervical disloca-
tion and exanguinated within 4 min of disturbance. Blood was
collected in EDTA-coated tubes on ice and was then centrifuged
at 3,000 rpm for 10 min. Plasma was collected and stored at
–20
 
 
 
C. Lungs were removed immediately after exanguination,
washed once in PBS, and placed on ice. Tissue was homogenized
and extracted in 2 ml of methanol. Corticosterone levels in
plasma and lung extracts were determined by radioimmunoassayT
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using a rat corticosterone 
 
3
 
H kit (ICN Pharmaceuticals). For lung
extracts, excess methanol was evaporated and the dried pellet was
dissolved in 0.5 ml of the steroid buffer supplied with the kit.
Corticosterone levels were determined using a standard curve and
expressed as ng/ml for plasma or ng/g of lung tissue.
 
Results
 
The gene encoding 3
 
 
 
-HSD in VV WR was originally
called SalF7L (19) but is hereafter called A44L using VV
strain Copenhagen nomenclature (26). Deletion of A44L
from VV WR abrogated v3
 
 
 
-HSD activity and caused vi-
rus attenuation in vivo (19). To explore further the role of
3
 
 
 
-HSD in VV virulence we constructed a revertant virus
(vA44L-rev) in which the A44L gene was reinserted into
the v
 
 
 
A44L mutant. This virus served as a control to ensure
that any phenotypic differences of v
 
 
 
A44L were due to loss
of the A44L protein and not due to mutations elsewhere in
the genome. Analysis of wild-type (vA44L), v
 
 
 
A44L, and
vA44L-rev viruses by PCR confirmed that the genomes
were as predicted. Furthermore, no differences were found
in the rate of replication or the final virus titer observed af-
ter infection of BS-C-1 cells with each of the viruses,
whether a high (10 PFU per cell) or low (0.01 PFU per
cell) multiplicity of infection was used (unpublished data).
The plaque morphology formed by each virus on BS-C-1
cells was also indistinguishable (unpublished data).
Next, expression of 3
 
 
 
-HSD was measured in vitro by
the conversion of [
 
3
 
H]-pregnenolone to [
 
3
 
H]-progester-
one. As seen in Fig. 1 A, vA44L- and vA44L-rev–infected
CV-1 cells exhibited 3
 
 
 
-HSD activity but mock- and
v
 
 
 
A44L-infected cells did not. In addition, all 8 strains of
VV tested converted [
 
3
 
H]-pregnenolone to [
 
3
 
H]-progester-
one, indicating v3
 
 
 
-HSD is conserved in VVs (Fig. 1 B).
 
Deletion of A44L Attenuates VV Strain WR In Vivo.
 
The role of the A44L protein in VV infection was explored
using a murine intranasal model. Mice infected with
vA44L, v
 
 
 
A44L, or vA44L-rev were weighed and assessed
for signs of illness (ruffled fur, reduced mobility, and tachy-
pnea) daily. Fig. 2 demonstrates the attenuated phenotype
of v
 
 
 
A44L relative to both vA44L and vA44L-rev viruses.
Mice infected with vA44L or vA44L-rev lost over 20% of
body weight during the infection (Fig. 2 A) and displayed
severe signs of illness (Fig. 2 B). In contrast, mice infected
with v
 
 
 
A44L lost significantly less weight, recovered more
rapidly, and displayed very mild signs of illness. There was
no significant difference between the weight loss profiles of
Figure 1. 3 -HSD activity in VV-infected cells. CV-1 cells were
mock-infected or infected at 10 PFU/cell with (A) vA44L, v A44L or
A44L-rev, or (B) different VV strains, and assayed for 3 -HSD activity at
8–10 h p.i. All infections were performed in triplicate and results are ex-
pressed as mean   SEM. The background values from nonenzymatic
conversion to progesterone (measured in ethanol-fixed monolayers) were
subtracted from each value.
Figure 2. Deletion of A44L attenuates VV WR infection in a murine
intranasal model. Groups of five BALB/c mice were mock-infected ( )
or infected with 104 PFU of vA44L ( ), v A44L ( ), or A44L-rev ( ).
(A) Mice were weighed daily and results are expressed as the mean per-
centage weight change of each group   SEM compared with the weight
immediately before infection. (B) Animals were monitored daily for signs
of illness, scored from 1 to 4. Data are expressed as the mean   SEM
from five mice. P values were determined using the Student’s t test and
indicate the mean % weight changes or signs of illness of mice infected
with v A44L that were significantly different from both those of mice in-
fected with vA44L or A44L-rev.T
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mice infected with vA44L or vA44L-rev indicating that the
attenuation seen with v A44L is due to loss of the A44L
gene.
VV WR gene B15R encodes a soluble IL-1  receptor
(27) that blocks IL-1 –induced fever (28). To determine if
A44L affected body temperature during VV infection, rec-
tal temperatures were taken daily after infection with
vA44L, v A44L, or vA44L-rev viruses. No differences
were noted in the body temperatures of animals infected
with these viruses (unpublished data) indicating that A44L
affects virulence through an alternative mechanism(s).
Virus Replication and Spread In Vivo. As the lung is the
site of primary infection in the intranasal model, we assayed
lung homogenates for infectious virus after infection with
vA44L, v A44L, or vA44L-rev. As shown in Fig. 3 A, all
three viruses had similar titers at 1 and 3 d pi, indicating
that A44L is not critical for the initial rounds of replication
in the lung. However, by the time peak titers of virus oc-
curred at 7 d pi the level of infectivity in the lungs of
vA44L and vA44L-rev–infected mice was significantly
greater than that in mice infected with v A44L. These ob-
servations were consistent in multiple experiments (n   4).
By day 12, infectious virus could be detected in the lungs
of only 1/5 v A44L-infected animals compared with 5/5
in each of the other groups.
WR is a neurovirulent strain of VV that was derived by
repeated passage in suckling mouse brain (29). In the mu-
rine intranasal model, VV strain WR infection is accompa-
nied by extensive respiratory infection and virus dissemina-
tion to multiple organs (30, 31). To examine the ability of
the three viruses to spread and replicate in extrapulmonary
sites, homogenates of brain, spleen, and liver were assayed
for infectious virus. Virus titers were below detection levels
in all organs at day 1 pi, however by day 3 infectious virus
was recovered from brain, spleen, and liver of all mice in-
fected with vA44L or vA44L-rev, and from the spleen and
livers of all v A44L-infected animals (Fig. 3, B, C, and D).
Infectivity titers were similar in all groups at this time, ex-
cept in the brain of v A44L-infected mice, where virus
was recovered from only 1/5 animals. By day 7, virus titers
were reduced in all organs examined from v A44L-infected
mice compared with controls, indicating that while this vi-
rus is capable of in vivo spread, it is cleared more rapidly
from the brain, liver, spleen, and lungs compared with
vA44L and vA44L-rev viruses. Virus was still present in
lungs of VV-infected animals 12 d pi; however, it had been
cleared from all other organs examined by this time.
To investigate if vA44L, v A44L, and vA44L-rev could
replicate to similar levels in murine cells in vitro, cultures of
primary fibroblasts were prepared from the kidneys of naive
BALB/c mice (Materials and Methods). The replication ki-
netics of the three viruses were indistinguishable during ei-
ther single-step (10 PFU/cell) or multistep (0.01 PFU/cell)
growth curves (unpublished data); the latter conditions are
particularly sensitive to accentuating small differences in
growth between viruses. Our findings that (a) the rate of vi-
rus replication and the maximum virus titer obtained in
lungs after infection with vA44L, v A44L, and vA44L-rev
was not statistically different over the first three days of in-
fection (Fig. 3 A), and (b) that there was no difference in the
replicative capacity of the viruses in a primary mouse cul-
ture, indicated that the difference in virulence between these
viruses was probably due to effects of v3 -HSD on host an-
tiviral mechanisms rather than altered replicative ability.
Analysis of BAL Cells from Lungs of VV-infected Mice.
The swifter clearance of virus after infection with v A44L
suggested a more effective antiviral host response against
Figure 3. Titers of vA44L, v A44L, and A44L-rev in the lungs (A),
brains (B), spleens (C), and livers (D). Groups of five mice were infected
intranasally with 104 PFU of VV and the lungs, brains, spleens, and livers
were harvested on the days indicated. Organs were homogenized and
stored at –70 C and the titer of infectious virus was determined by plaque
assay on BS-C-1 cells. Virus titers are expressed as mean log10 PFU per or-
gan, with SEM. The broken line indicates the minimum detection limit of
the plaque assay. Columns marked with an asterisk represent virus titers
from v A44L-infected mice that were significantly different to those from
both vA44L- and vA44L-infected animals. *, P   0.05, **, P   0.02.T
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this virus and therefore the cellular inflammatory response
was assessed. BALs were performed at various times pi and
the numbers of viable cells were determined. Few cells
were recovered from BAL of mock-infected animals or 1 d
pi with 104 PFU of VV, indicating there were only low
levels of recruitment to the lung in the early phase of VV
infection (Fig. 4 A). BAL cell numbers increased over time
with peak numbers 12 d pi with vA44L or vA44L-rev, and
7 d pi with v A44L. Significantly more cells were recov-
ered from v A44L-infected mice at day 7 pi compared
with other VV-infected groups.
Cytospins of BAL cells were stained with hematoxylin
and eosin for differential cell counts (Fig. 4, B and C). Un-
infected mouse BAL cells were composed almost entirely
of macrophages, with some ( 10%) lymphocytes noted.
The majority of inflammatory cells recruited to the lung
during the course of VV infection were macrophages (Fig.
4 B) and lymphocytes (Fig. 4 C), with granulocytes repre-
senting less than 5% of total cells at all time points tested
(unpublished data). The enhanced recruitment of lympho-
cytes to the lungs of v A44L-infected mice at day 7 corre-
lated with the more rapid clearance of this virus from the
lungs (Fig. 3 A). Notably, by day 12 pi with v A44L the
levels of total cells, macrophages, and lymphocytes in BALs
were all lower than on day 7, whereas with vA44L and
vA44L-rev the cell numbers were higher on day 12 than
day 7.
A striking feature of the cellular inflammatory response
to v A44L was the early recruitment of lymphocytes (Fig.
4 C). Therefore, flow cytometric analysis was used to ex-
amine lymphocyte subsets in BAL at day 7 pi. A greater
percentage of both CD4  (Fig. 4 D) and CD8  (Fig. 4 E)
lymphocytes were observed in BAL from v A44L-infected
mice compared with animals infected with vA44L or
vA44L-rev. Less than 5% of BAL cells were DX5  NK
cells or B220  B lymphocytes at this time (unpublished
data). These data show that by day 7 pi with v A44L more
cells were recruited to the lungs and a higher proportion of
these were CD4  and CD8  T cells.
Analysis of IFN-  Production in the Lungs of VV-infected
Mice. Fig. 4 indicates an increased presence of CD4  and
CD8  T cells within the lungs of v A44L-infected mice;
however, functional analysis of these cells was required.
IFN-  plays an important role in antiviral host defense fol-
lowing infection of mice with VV or other poxviruses (32–
34). Given the enhanced recruitment of T cells to the lungs
of v A44L-infected mice and the ability of both CD4  and
CD8  T lymphocytes to produce antiviral cytokines, the
level of IFN-  in BAL fluids was determined (Fig. 5 A).
IFN-  levels in BAL fluids from mock-infected animals
were below the detection limit of the assay. Low levels of
IFN-  were detected in lavage 3 d pi and these increased
markedly at days 7 and 10 pi. Significantly higher levels of
IFN-  were detected from v A44L-infected mice com-
pared with animals infected with control viruses at day 7 pi.
IFN-  levels at day 10 were also generally higher in mice
infected with v A44L (Fig. 5 A). Levels of IL-10 or IL-4 in
BAL fluid were below the detection limit of their respective
ELISA assays at each time point tested (unpublished data).
Next, IFN-  production was determined after culturing
lung cell suspensions in the presence of PMA and ionomy-
cin for 5 h at 37 C. IFN-  levels were very low in lung cell
Figure 4. Characterization of BAL cell suspensions from
mice infected with 104 PFU of vA44L, v A44L, or
vA44L-rev. BAL cells were recovered, counted, and
stained to determine the numbers of (A) total cells, (B)
macrophages, and (C) lymphocytes from mock-infected
and VV-infected mice. Columns represent the mean cell
yield per mouse   SEM from groups of 4–5 mice. Col-
umns marked with an asterisk represent mean cell numbers
recovered from v A44L-infected mice that were signifi-
cantly different (*, P   0.05) to those of both vA44L and
vA44L-rev-infected mice. (D and E) At 7 d pi, BAL cells
were recovered, stained for expression of CD3, CD4, and
CD8 and analyzed by flow cytometry. Lymphocytes were
identified by their characteristic FSC/SSC profile and by
expression of CD3. Data shown are the mean percentage
of BAL cells   SEM from 4–5 individual mice, and are
representative of two independent experiments.T
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supernatants from mock-infected mice (Fig. 5 B). A mod-
est increase was observed in supernatants from lung cells
3 d pi, and levels were elevated further from lung cells har-
vested days 7 and 10 pi. Consistent with IFN-  levels ob-
served in BAL, PMA-stimulated lung cells from v A44L-
infected mice produced significantly more IFN-  than
those from animals infected with vA44L or vA44L-rev on
days 7 and 10 pi (Fig. 5 B).
The elevated IFN-  production detected in BAL fluids
and lung cell suspensions from v A44L-infected mice sug-
gested that the additional lymphocytes recruited to the
lungs of these animals were producing IFN- . Intracellular
staining of lung lymphocytes for IFN-  on days 3, 7, and
10 pi demonstrated that the proportion of both CD4  and
CD8  lymphocytes positive for IFN-  was higher in the
lungs of v A44L-infected mice at days 7 and 10 pi (Fig. 5
C, D). Only a very low proportion of CD4  or CD8  cells
( 5%) stained for IL-4 or IL-10 in any of the groups (un-
published data).
Analysis of Cytolytic Activity of Lymphocytes Isolated from
VV-infected Lungs. To assess the effect of VV 3 -HSD on
VV-specific CTL activity, the cytotoxic activity of cells
from lung cell suspensions was examined against VV-
infected or uninfected P815 cells (Fig. 6). At day 5, pri-
mary CTL activity was very low in lung cell suspensions
from all infected animals (  10%, unpublished data); how-
ever, by day 7 significant CTL activity was detected against
VV-infected targets (Fig. 6 A). The cytolytic activity of
lung lymphocytes from v A44L-infected mice was greater
than from mice infected with vA44L or vA44L-rev, and
this trend was also observed using lung cells from animals
10 d pi. (Fig. 6 B). All lung cell suspensions showed very
weak cytotoxic activity against uninfected P815 cells (less
than 10% at effector:target ratio of 100:1). Furthermore, no
significant cytotoxic activity was observed against the NK-
sensitive YAC-1 cell line (unpublished data).
The increase in cytotoxic activity of lung cells from
v A44L-infected mice may represent increased recruitment
of CTL effectors or an increased activation state of the cells.
Figure 5. Production of IFN-  in the lungs of VV-infected mice.
Groups of 4–6 BALB/c mice were mock-infected or infected with 104
PFU of vA44L, v A44L, or vA44L -rev. At days 3, 7, and 10 mice were
killed, BALs were performed and single cell suspensions were prepared
from lung tissue. (A) Levels of IFN-  in BAL fluids of VV-infected mice.
BAL fluid was centrifuged and the level of IFN-  present in the superna-
tant was determined by ELISA. Values represent the mean, with SEM,
from two groups (n   3/group). The dashed line represents the detection
limit of the IFN-  ELISA (50 pg/ml). (B) IFN-  production from lung
cells. Lung cell suspensions were stimulated with PMA and ionomycin for
5 h as described in Materials and Methods. Cells were pelleted and level of
IFN-  present in the supernatant was determined by ELISA. Values repre-
sent the mean   SEM, from two groups (n   3/group). The dashed line
represents the detection limit of the IFN-  ELISA (50 pg/ml). (C and D)
Intracellular production of IFN-  by lung lymphocytes from mice 7 d after
intranasal VV. Lung cells were stimulated with PMA and ionomycin for
4 h; brefeldin A was added to retain cytokines in the cytoplasm. Cells were
stained with FITC-labeled anti-CD8, APC-labeled anti-CD4, and after
permeabilization using saponin, with PE-labeled anti–IFN-  before analy-
sis by three-color flow cytometry. Shown are the percentages of CD8  (C)
or CD4  (D) T cells producing IFN- . Values are averaged from two
groups (n   3/group). The frequency of IL-4-producing cells was below
the detection limit ( 2%) and is not shown. *, P   0.05, **, P   0.02.
Figure 6. Virus-specific CTL activity in the lung of VV-infected mice.
Groups of six mice were infected with 104 PFU of vA44L ( ), v A44L
( ), or vA44L-rev ( ). At days 7 (A and C) and 10 (B and D) mice were
killed and lung cell suspensions were prepared. Specific lysis of WR-
infected P815 cells was assessed by 51Cr-release assay. Data are expressed
as the mean percent specific lysis   SEM from two groups of three mice
plotted against the lung cell:target ratio (A and B) or the CD8  lung
cell:target ratio (C and D). Lysis of uninfected P815 cells by day 7 and day
10 effector cell populations was always  10% at an effector:target ratio of
100:1 (unpublished data).T
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To confirm that CD8  T lymphocytes were mediating
CTL activity, day 7 lung cells from VV-infected mice were
treated with complement plus a mAb to murine CD8. This
treatment abrogated virtually all CTL activity (undepleted  
56% specific lysis, complement alone   46%, complement
plus anti-CD8   3%, at effector:target ratio of 100:1).
The numbers of CD8  lymphocytes in the lung cell sus-
pensions were determined by flow cytometry, and used to
compare CTL activity between lung cells based on a CD8 
lung cell:target ratio (Fig. 6, C and D). The enhanced lysis
observed using lung cells from v A44L-infected mice is
partly explained by the higher relative numbers of CD8  T
cells in this compartment (7.4   2.2%, 13.6   2.0%, and
8.0   1.9% of total lung cells at day 7, and 14.5   3.8%,
25.1   4.7%, and 13.5   3.0% of total lung cells at day 10
from mice infected with vA44L, v A44L and vA44L-rev,
respectively). However, CTL from v A44L-infected mice
also show an enhanced level of lysis on a per cell basis con-
sistent with an enhanced activation state of virus-specific
CTL within the T cell population (Fig. 6, C and D).
Levels of Corticosterone in Plasma and Lungs of VV-infected
Mice. Data presented so far have demonstrated that the
v A44L mutant is markedly attenuated in the murine in-
tranasal model, and that after an initial period of 3–4 d
when infection with each virus was indistinguishable, the
attenuated phenotype of the v A44L mutant was accom-
panied by a more vigorous cellular inflammatory response
in the lungs of infected mice. As the A44L encodes an ac-
tive 3 -HSD and GCs and other steroids possess important
immunomodulatory functions, the levels of corticosterone
were determined in the plasma and lungs of VV-infected
mice (Fig. 7, A and B). Corticosterone is released after
stress and as part of the acute phase response to infection,
therefore we determined levels only at times when all indi-
cators of disease (and therefore stress) were similar between
groups. At days 1, 2, and 4 virus titers were similar in the
lungs of vA44L-, v A44L-, or vA44L-rev–infected mice
(Fig. 7 C), and no differences were observed in visible signs
of illness, weight loss, body temperature, or the number of
inflammatory cells and IFN-  levels recovered from the
BAL of infected mice (unpublished data). Corticosterone
levels were, however, significantly lower in plasma at days
1 and 2 (Fig. 7 A) and in lung extracts at days 2 and 4 (Fig.
7 B) from v A44L-infected mice. After day 4 any differ-
ences in corticosterone levels between the groups would be
difficult to interpret because the attenuated phenotype of
v A44L is apparent and therefore stress levels might vary
between groups. The enhanced levels of endogenous GCs
observed in vA44L and vA44L-rev–infected mice suggest
that A44L may have a direct effect upon local and systemic
steroid levels during VV infection.
Discussion
VV and other poxviruses encode many proteins that inter-
fere with specific components of the immune system. Here
we have examined the biological significance of the A44L
protein from VV strain WR by comparing the virulence of
wild-type WR (vA44L), a mutant lacking 86% of the A44L
ORF (v A44L), and a revertant virus where the A44L ORF
was reinserted into its original locus (vA44L-rev). The results
demonstrate that A44L is an important virulence factor of
VV and has potent immunosuppressive properties.
First, this study confirmed that deletion of A44L from
VV strain WR reduced virus virulence following intranasal
Figure 7. Corticosterone levels in plasma and lungs after intranasal in-
fection with VV. Corticosterone levels were measured in (A) plasma and
(B) lung extracts collected from BALB/c mice under low stress conditions
(samples were obtained within 4 min of handling) at the indicated times
after intranasal infection with 105 PFU of vA44L, v A44L, or A44L-rev.
Lung extracts were prepared as described in Materials and Methods. Data
represent mean   SEM of four or five mice per time point and are ex-
pressed as ng/ml of plasma or as ng/g of lung tissue. Columns marked
with an asterisk represent corticosterone levels from v A44L-infected mice
that were significantly different to those from vA44L- and vA44L-rev-
infected mice. *, P   0.05, **, P   0.02. (C) Titers of infectious virus in
the lungs of mice after infection with 105 PFU of VV. Virus titers were
determined by plaque assay on BS-C-1 cells and are expressed as PFU/g
of lung tissue.T
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infection. Previously, it was reported that mice infected in-
tranasally with v A44L showed reduced mortality and rel-
atively mild weight loss compared with those infected with
parental strain WR (19). In the current study, we also re-
port that v A44L-infected mice showed milder signs of ill-
ness and do not develop ruffled fur, reduced mobility, and
tachypnea that are characteristic of VV-induced pneumonia
(Fig. 2 B). In contrast, Sroller et al. (20) reported that loss
of A44L caused only a modest reduction in virulence. In
the current study the inclusion a revertant virus strengthens
our conclusion that A44L is a virulence factor in the mu-
rine intranasal model, as it is in the murine intradermal
model (21).
Second, this study demonstrated that although (a)
vA44L, v A44L, and vA44L-rev viruses replicated to simi-
lar levels in primary murine fibroblasts, (b) in repeated ex-
periments virus titers in the lungs of vA44L, v A44L, and
vA44L-rev-infected animals were equivalent on days 1–3
pi, and (c) all 3 viruses were capable of spread and replica-
tion in secondary organs (brain, liver, spleen), the v A44L
virus was cleared more rapidly. These findings indicate that
A44L is not critical for the initial rounds of virus replication
in the host and that the difference between the viruses
probably reflects host antiviral mechanisms. The rapid
clearance of v A44L coincided with an early influx of in-
flammatory leukocytes, in particular T lymphocytes, into
the lungs. Functional analysis demonstrated that IFN- 
production and VV-specific CTL activity were enhanced
in these lymphocytes. This phenotype was consistent with
the A44L protein interfering with aspects of the proinflam-
matory host response.
The VV WR A44L gene encodes a 3 -HSD enzyme
(19). The mammalian 3 -HSD enzyme catalyzes the con-
version of  5-3 -hydroxysteroids to  4-3-ketosteroids, a
reaction that is required for the biosynthesis of all classes of
steroid hormones. Therefore, the most likely role for A44L
in VV pathogenesis is in the production of steroid hor-
mones such as GCs that are immunosuppressive and are
used widely in the therapy of inflammatory, autoimmune,
and allergic diseases (5). GCs have the potential to affect
multiple aspects of the antiviral immune response. Previous
studies established that restraint stress (RST) reduced the
accumulation of leukocytes in the lungs of influenza virus-
infected mice and this response was dependent upon ele-
vated serum GCs as treatment with the GC receptor an-
tagonist RU486 restored cellular infiltration (35). RST
suppression of influenza virus-specific production of cyto-
kines such as IL-2 and IFN-  was also reversed by RU486
treatment (36). By analogy, our findings that infection of
mice with v A44L was associated with enhanced leuko-
cyte infiltration (Fig. 4) and IFN-  production (Fig. 5) in
the lung is consistent with A44L-mediated enhancement
of GC levels in vivo following infection with vA44L and
vA44L-rev viruses.
GC release through the hypothalamic-pituitary-adrenal
(HPA) axis occurs as part of circadian rhythm (37) and is
induced by additional stimuli including physical or cogni-
tive stress (38) and cytokine responses to bacterial LPS (39,
40) or viruses such as murine cytomegalovirus (41). Intra-
nasal infection of mice with VV led to increased levels of
corticosterone, a GC, in plasma and in the lung compared
with uninfected mice (Fig. 7). Moreover, there was a sig-
nificant increase in plasma and lung corticosterone levels in
vA44L- and vA44L-rev–infected mice compared with ani-
mals infected with v A44L (Fig. 7) at times when all other
indicators of disease (weight loss, signs of illness, body tem-
perature, recovery of inflammatory cells from BAL, IFN- 
levels, and virus titres) were similar between groups. Later
time points were not examined because any differences in
corticosterone levels could be due to either the A44L pro-
tein or the more severe illness and stress caused by viruses
expressing this protein.
A striking feature of the inflammatory response to
v A44L was the rapid recruitment of leukocytes to the
lungs, in particular CD4  and CD8  T lymphocytes with
the potential to produce IFN-  (Fig. 5) and CD8  CTLs
(Fig. 6), indicating that A44L can suppress at least two im-
portant components of the antiviral host response. MHC
class I–restricted, CD8  CTL and IFN-  play an important
role in the resolution of acute infection by poxviruses such
as VV (32, 42, 43). VV is very sensitive to IFN-  in vitro
(44) and IFN-  production is critical for recovery of mice
after VV infection (32, 33, 42, 45). Poxviruses encode sev-
eral intracellular and extracellular proteins to interfere with
the production or action of IFN- ; however, the VV IFN- 
receptor secreted from infected cells does not neutralize
mouse IFN-  (46–49). CD8  CTLs are key mediators of
viral clearance by cytolysis of virus-infected cells and the
secretion of cytokines such as IFN-  and TNF- . Interest-
ingly, GCs also suppress CTL activity (50).
A44L is nonessential for virus replication in vitro; how-
ever, it is quite well conserved amongst members of the
poxvirus family. All 8 VV strains tested expressed 3 -HSD
activity (Fig. 1 B) and similar activity has been described in
cells infected with VV strains Praha, LIVP, and MVA (20)
as well as the avipoxviruses fowlpox and canarypox (51) and
a fish iridiovirus (52). The gene is also highly conserved in
other sequenced orthopoxviruses (camelpox, ectromelia,
cowpox, and monkeypox) and other poxvirus genera (sui-
poxvirus, molluscipoxvirus, and yatapoxvirus) suggesting
the v3 -HSD plays an important role in poxvirus biology.
Interestingly, despite the presence of a closely related gene
in several variola strains, in each case the gene is disrupted
by mutation and is not predicted to encode an active 3 -
HSD (53–57). Deletion of the v3 -HSD from VV did not
enhance antibody responses to infection but the cell-medi-
ated immune responses were not examined (20).
It is apparent that VV and other poxviruses possess mul-
tiple genes that contribute to virulence by subverting the
host immune response or by altering virus dissemination
and/or tropism. Data presented here indicate that A44L is
immunosuppressive and interferes with the early events in
the host cellular response to VV infection, thus contribut-
ing to protracted virus replication and improved virus dis-
semination within the host. The removal of this gene from
poxvirus vaccines, such as modified vaccinia virus AnkaraT
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(MVA), is likely to enhance vaccine immunogenicity, par-
ticularly T cell responses to infection.
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